Patient Guide: Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 1 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT06420063
Status: 🟢 Enrolling Now
Condition: AML, Acute Myeloid Leukemia, AML, Adult Recurrent, AML, Adult
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 1 research site. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Beijing, Beijing

Loading interactive enrollment tools...

The full interactive experience will load momentarily